Sagent Pharmaceuticals, Inc. Appoints Michael Fekete to Its Board of Directors

Published: Jul 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SCHAUMBURG, Ill., July 11, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its Board of Directors has expanded the size of the Board from five to six members and appointed Michael Fekete as a Class I Director effective July 10, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news